NONO/AR–V7

About Talus Bioscience

Talus Bioscience is an early-stage biotech leveraging a proprietary platform to make the regulome, a previously hidden layer of gene control, accessible for drug discovery. Its technology combines AI-designed chemical libraries, high-throughput functional proteomics, and machine learning models to identify and drug transcription factors and other regulatory proteins implicated in disease. The company is advancing an internal pipeline of first-in-class programs in oncology and immunology while also exploring strategic partnerships to expand its reach.

Therapeutic Areas